Literature DB >> 17981613

Class IIA HDACs in the regulation of neurodegeneration.

Nazanin Majdzadeh1, Brad E Morrison, Santosh R D'Mello.   

Abstract

Neurodegenerative diseases affect millions of patients annually and are a significant burden on the health care systems around the world. While there are symptomatic remedies for patients suffering from various neurodegenerative diseases, there are no cures as of today. Cell death by apoptosis is a common hallmark of neurodegeneration. Therefore, deciphering the molecular pathways regulating this process is of significant value to scientists' endeavor to understand neurodegenerative disorders. Efforts along these lines have uncovered a number of molecular pathways that regulate neuronal apoptosis. Recently, a family of proteins known as histone deacetylases (HDACs) has been linked to regulation of cell survival as well as death. The focus of this review is to summarize our current understanding of the role of HDACs and in particular a subgroup of proteins in this family classified as class IIa HDACs in the regulation of neuronal cell death. It is apparent based on the information presented in this review that although very similar in their primary sequence, members of this family of proteins often have distinct roles in orchestrating apoptotic cell death in the brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981613      PMCID: PMC2691610          DOI: 10.2741/2745

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  89 in total

Review 1.  Amyloid diseases: abnormal protein aggregation in neurodegeneration.

Authors:  E H Koo; P T Lansbury; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 2.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression.

Authors:  Alexandre Méjat; Francis Ramond; Rhonda Bassel-Duby; Saadi Khochbin; Eric N Olson; Laurent Schaeffer
Journal:  Nat Neurosci       Date:  2005-02-13       Impact factor: 24.884

4.  HDAC-3 participates in the repression of e2f-dependent gene transcription in primary differentiated neurons.

Authors:  Irina Panteleeva; Caroline Rouaux; Yves Larmet; Stéphanie Boutillier; Jean-Philippe Loeffler; Anne-Laurence Boutillier
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

5.  The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation.

Authors:  Barrington G Burnett; Randall N Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

6.  Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein.

Authors:  M Iizuka; B Stillman
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

7.  Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis.

Authors:  Rick B Vega; Koichi Matsuda; Junyoung Oh; Ana C Barbosa; Xiangli Yang; Eric Meadows; John McAnally; Chris Pomajzl; John M Shelton; James A Richardson; Gerard Karsenty; Eric N Olson
Journal:  Cell       Date:  2004-11-12       Impact factor: 41.582

8.  Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease.

Authors:  Gabriella Gardian; Susan E Browne; Dong-Kug Choi; Peter Klivenyi; Jason Gregorio; James K Kubilus; Hoon Ryu; Brett Langley; Rajiv R Ratan; Robert J Ferrante; M Flint Beal
Journal:  J Biol Chem       Date:  2004-10-19       Impact factor: 5.157

9.  Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity.

Authors:  Gabriella Gardian; Lichuan Yang; Carine Cleren; Noel Y Calingasan; Peter Klivenyi; M Flint Beal
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

10.  DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2.

Authors:  Shoumei Bai; Kalpana Ghoshal; Jharna Datta; Sarmila Majumder; Sung Ok Yoon; Samson T Jacob
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

View more
  22 in total

1.  Conditional deletion of histone deacetylase-4 in the central nervous system has no major effect on brain architecture or neuronal viability.

Authors:  Valerie Price; Lulu Wang; Santosh R D'Mello
Journal:  J Neurosci Res       Date:  2012-12-14       Impact factor: 4.164

2.  Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹⁸F-FAHA.

Authors:  Hsin-Hsien Yeh; Mei Tian; Rainer Hinz; Daniel Young; Alexander Shavrin; Uday Mukhapadhyay; Leo G Flores; Julius Balatoni; Suren Soghomonyan; Hwan J Jeong; Ashutosh Pal; Rajesh Uthamanthil; James N Jackson; Ryuichi Nishii; Hiroshi Mizuma; Hirotaka Onoe; Shinya Kagawa; Tatsuya Higashi; Nobuyoshi Fukumitsu; Mian Alauddin; William Tong; Karl Herholz; Juri G Gelovani
Journal:  Neuroimage       Date:  2012-09-17       Impact factor: 6.556

Review 3.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

4.  Dephosphorylation at a conserved SP motif governs cAMP sensitivity and nuclear localization of class IIa histone deacetylases.

Authors:  Donald R Walkinshaw; Ryan Weist; Lin Xiao; Kezhi Yan; Go-Woon Kim; Xiang-Jiao Yang
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

5.  Stroke Induces Nuclear Shuttling of Histone Deacetylase 4.

Authors:  Haifa Kassis; Amjad Shehadah; Michael Chopp; Cynthia Roberts; Zheng Gang Zhang
Journal:  Stroke       Date:  2015-05-12       Impact factor: 7.914

Review 6.  Computational studies on the histone deacetylases and the design of selective histone deacetylase inhibitors.

Authors:  Difei Wang
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

7.  Polydactyly in mice lacking HDAC9/HDRP.

Authors:  Brad E Morrison; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2008-05-14

Review 8.  Histone deacetylases as targets for the treatment of human neurodegenerative diseases.

Authors:  Santosh R D'Mello
Journal:  Drug News Perspect       Date:  2009-11

9.  A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties.

Authors:  Thong C Ma; Brett Langley; Brian Ko; Na Wei; Irina G Gazaryan; Neela Zareen; Darrell J Yamashiro; Dianna E Willis; Rajiv R Ratan
Journal:  Neurobiol Dis       Date:  2012-08-27       Impact factor: 5.996

10.  Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia.

Authors:  Jiali Li; Jianmin Chen; Christopher L Ricupero; Ronald P Hart; Melanie S Schwartz; Alexander Kusnecov; Karl Herrup
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.